TP53 and cholangiocarcinoma: The four biomarkers panel consist of CD56, p53, SMAD4, and CEA assessed by the present study but the results showed significant relationships just between the expression of p53 (74% positivity rate, P < 0.001) and CEA (79.6% positivity rate, P = 0.002) with CCA.